Regeneca Worldwide a division of VivaCeuticals Inc. of Las Vegas has issued a nationwide recall of RegenESlim appetite control dietary supplement because it contains 1,3-dimethylamylamine (DMAA) an unapproved drug that can pose serious health risks. Although no illnesses have been reported in connection with this product, the U.S. Food and Drug Aministration (FDA) has received more than 86 reports of illnesses and death associated with supplements containing DMAA.
Consumers who have purchased this product should not use it. DMAA is a stimulant that can narrow blood vessels and arteries, causing a rise in blood pressure or other cardiovascular problems such as shortness of breath, tightening in the chest, irregular heartbeat and heart attack. It can also cause problems with the nervous system. It may be especially dangerous when used in combination with caffeine
The recalled product are from the lot # EX0616R15814 and lot #11414RE5516 packaged in 3 ½” by 3” green and white sachets that contain 2 capsules, with the name RegeneSlim displayed prominently on the front of the sachet. RegeneSlim is purchased by and distributed through a direct sales force within the United States and Puerto Rico, and through online sales, for both personal consumption and retail sales.
The recall was issued after an FDA analysis of the product confirmed the presence of DMAA. The company continues their investigation as to the cause of the problem.
